Vijay K Iyengar sold $456k of INCY
EVP, GMAPPS at INCYTE CORP. 6,043 shares at an average of $75.38, traded Nov 29, 2024, filed Dec 3, 2024.
Score components
- +15RoleOfficer
- +17Trade size$456k at market
- +5Share of holdings soldSold 16% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000879169-24-000176, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 29, 2024 | SOpen-market sale Common Stock10b5-1 | -360 | $75.60 | $27k | 36,341 | Dec 3, 2024 |
| Nov 29, 2024 | SOpen-market sale Common Stock10b5-1 | -5,683 | $75.37 | $428k | 30,658 | Dec 3, 2024 |
Related signals
Other insiders at INCYTE CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | INCYTE CORP | Pablo J Cagnoni President, Global Head of R&D | $2.8M 23,218 shares | -11% | |
| 0Weak | INCYTE CORP | Sheila A. Denton EVP & General Counsel | $122k 1,795 shares | -6% | |
| 38Weak | INCYTE CORP | Barry P Flannelly EVP & General Manager US | $1.3M 19,807 shares | -37% | |
| 0Weak | INCYTE CORP | Sheila A. Denton EVP & General Counsel | $42k 599 shares | -2% | |
| 15Weak | INCYTE CORP | Sheila A. Denton EVP & General Counsel | $1.0M 14,069 shares | -35% | |
| 24Weak | INCYTE CORP | Steven H Stein EVP & Chief Medical Officer | $898k 12,352 shares | -16% | |
| 12Weak | INCYTE CORP | Thomas Tray Principal Accounting Officer | $91k 1,300 shares | -5% | |
| 0Weak | INCYTE CORP | Barry P Flannelly EVP & General Manager US | $293k 3,680 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.